410 related articles for article (PubMed ID: 18022314)
1. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
Duan R; Ginsburg E; Vonderhaar BK
Mol Cell Endocrinol; 2008 Jan; 281(1-2):9-18. PubMed ID: 18022314
[TBL] [Abstract][Full Text] [Related]
2. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
Manfroid I; Van de Weerdt C; Baudhuin A; Martial JA; Muller M
Mol Cell Endocrinol; 2005 Jan; 229(1-2):127-39. PubMed ID: 15607537
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
4. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
5. Pituitary-type transcription of the human prolactin gene in the absence of Pit-1.
Gellersen B; Kempf R; Telgmann R; DiMattia GE
Mol Endocrinol; 1995 Jul; 9(7):887-901. PubMed ID: 7476971
[TBL] [Abstract][Full Text] [Related]
6. Role of Estrogen Response Element in the Human Prolactin Gene: Transcriptional Response and Timing.
McNamara AV; Adamson AD; Dunham LS; Semprini S; Spiller DG; McNeilly AS; Mullins JJ; Davis JR; White MR
Mol Endocrinol; 2016 Feb; 30(2):189-200. PubMed ID: 26691151
[TBL] [Abstract][Full Text] [Related]
7. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations.
Pernasetti F; Caccavelli L; Van de Weerdt C; Martial JA; Muller M
Mol Endocrinol; 1997 Jun; 11(7):986-96. PubMed ID: 9178758
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Martini PG; Katzenellenbogen BS
Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.
Petz LN; Ziegler YS; Loven MA; Nardulli AM
Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585
[TBL] [Abstract][Full Text] [Related]
11. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.
Adamson AD; Friedrichsen S; Semprini S; Harper CV; Mullins JJ; White MR; Davis JR
Endocrinology; 2008 Feb; 149(2):687-94. PubMed ID: 18006630
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor AP1 is involved in basal and okadaic acid-stimulated activity of the human PRL promoter.
Caccavelli L; Manfroid I; Martial JA; Muller M
Mol Endocrinol; 1998 Aug; 12(8):1215-27. PubMed ID: 9717847
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
14. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
15. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.
Smith LH; Coats SR; Qin H; Petrie MS; Covington JW; Su M; Eren M; Vaughan DE
Circ Res; 2004 Aug; 95(3):269-75. PubMed ID: 15217907
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and estrogen receptor-alpha depends on the coactivator subtype, the type of estrogen response element, and the promoter context.
Barkhem T; Haldosén LA; Gustafsson JA; Nilsson S
Mol Endocrinol; 2002 Nov; 16(11):2571-81. PubMed ID: 12403846
[TBL] [Abstract][Full Text] [Related]
17. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
18. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor.
Bahadur U; Ganjam GK; Vasudevan N; Kondaiah P
Mol Cell Endocrinol; 2005 Feb; 231(1-2):1-11. PubMed ID: 15713531
[TBL] [Abstract][Full Text] [Related]
19. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter.
Petz LN; Nardulli AM
Mol Endocrinol; 2000 Jul; 14(7):972-85. PubMed ID: 10894148
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
